P-017 Triple therapy versus dual antiplatelet therapy for dolichoectatic vertebrobasilar fusiform aneurysms treated with flow-diverters: the last frontier?

ConclusionsPatients with dolichoectatic VBFAs treated with flow-diversion and kept under triple therapy had less ischemic strokes, less progression of symptoms and overall better outcomes at last follow-up than similar patients kept under DAPT.Disclosures A. Siddiqui: 2; C; Amnis Therapeutics, Apellis Pharmaceuticals, Inc., Boston Scientific, Canon Medical Systems USA, Inc., Cardinal Health 200, LLC, Cerebrotech Medical Systems, Inc., Cerenovus, Cerevatech Medical, Inc.. 4; C; Adona Medical, Inc., Amnis Therapeutics, Bend IT Technologies, Ltd., BlinkTBI, Inc, Buffalo Technology Partners, Inc., Cardinal Consultants, LLC, Cerebrotech Medical Systems, Inc, Cerevatech Medical. A. Monteiro: None. R. Hanel: None. P. Kan: None. A. Mohanty: None. G. Cortez: None. M. Rabinovich: None. C. Matouk: None. N. Sujijantarat: None. K. Ebersole: None. L. Fry: None. S. Natarajan: None. B. Owusu-Adjei: None. S. Ortega-Gutierrez: None. J. Vivanco-Suarez: None. A. Wakhloo: None. E. Levy: 2; C; Claret Medical, GLG Consulting, Guidepoint Global, Imperial Care, Medtronic, Rebound, StimMed, Misionix, Mosiac, Clarion, IRRAS. 3; C; Medtronic. 4; C; NeXtGen Biologics, RAPID Medical, Claret Medical, Cognition Medical, Imperative Care, Rebound Therapeutics, StimMed, Three Rivers Medical.

Source: Journal of NeuroInterventional Surgery - July 23, 2022 Category: Neurosurgery Authors: Siddiqui, A., Monteiro, A., Hanel, R., Kan, P., Mohanty, A., Cortez, G., Rabinovich, M., Matouk, C., Sujijantarat, N., Ebersole, K., Fry, L., Natarajan, S., Owusu-Adjei, B., Ortega-Gutierrez, S., Vivanco-Suarez, J., Wakhloo, A., Levy, E. Tags: SNIS 19th annual meeting oral poster abstracts Source Type: research